Yang Hong, Negishi Kazuaki, Otahal Petr, Marwick Thomas H
Menzies Institute for Medical Research , Hobart, Tasmania , Australia.
Open Heart. 2015 Apr 10;2(1):e000222. doi: 10.1136/openhrt-2014-000222. eCollection 2015.
Early treatment may alter progression to overt heart failure (HF) in asymptomatic individuals with stage B HF (SBHF). However, the identification of patients with SBHF is difficult. This systematic review sought to examine the strength of association of clinical factors with incident HF, with the intention of facilitating selection for HF screening.
Electronic databases were systematically searched for studies reporting risk factors for incident HF. Effect sizes, typically HRs, of each risk variable were extracted. Pooled crude and adjusted HRs with 95% CIs were computed for each risk variable using a random-effects model weighted by inverse variance.
Twenty-seven clinical factors were identified to be associated with risk of incident HF in 15 observational studies in unselected community populations which followed 456 850 participants over 4-29 years. The strongest independent associations for incident HF were coronary artery disease (HR=2.94; 95% CI 1.36 to 6.33), diabetes mellitus (HR=2.00; 95% CI 1.68 to 2.38), age (HR (per 10 years)=1.80; 95% CI 1.13 to 2.87) followed by hypertension (HR=1.61; 95% CI 1.33 to 1.96), smoking (HR=1.60; 95% CI 1.45 to 1.77), male gender (HR=1.52; 95% CI 1.24 to 1.87) and body mass index (HR (per 5 kg/m(2))=1.15; 95% CI 1.06 to 1.25). Atrial fibrillation (HR=1.88; 95% CI 1.60 to 2.21), left ventricular hypertrophy (HR=2.46; 95% CI 1.71 to 3.53) and valvular heart disease (HR=1.74; 95% CI 1.07 to 2.84) were also strongly associated with incident HF but were not examined in sufficient papers to provide pooled hazard estimates.
Prediction of incident HF can be calculated from seven common clinical variables. The risk associated with these may guide strategies for the identification of high-risk people who may benefit from further evaluation and intervention.
早期治疗可能会改变B期心力衰竭(SBHF)无症状个体发展为显性心力衰竭(HF)的进程。然而,识别SBHF患者很困难。本系统评价旨在研究临床因素与HF发病之间的关联强度,以便于选择HF筛查对象。
系统检索电子数据库中报告HF发病危险因素的研究。提取每个风险变量的效应量,通常为风险比(HR)。使用逆方差加权的随机效应模型计算每个风险变量的合并粗HR和调整后HR及其95%置信区间(CI)。
在15项观察性研究中,共识别出27个与未选择的社区人群HF发病风险相关的临床因素,这些研究在4至29年期间对456850名参与者进行了随访。与HF发病最强的独立关联因素为冠状动脉疾病(HR=2.94;95%CI 1.36至6.33)、糖尿病(HR=2.00;95%CI 1.68至2.38)、年龄(HR(每10岁)=1.80;95%CI 1.13至2.87),其次是高血压(HR=1.61;95%CI 1.33至1.96)、吸烟(HR=1.60;95%CI 1.45至1.77)、男性(HR=1.52;95%CI 1.24至1.87)和体重指数(HR(每5kg/m²)=1.15;95%CI 1.06至1.25)。心房颤动(HR=1.88;95%CI 1.60至2.21)、左心室肥厚(HR=2.46;95%CI 1.71至3.53)和心脏瓣膜病(HR=1.74;95%CI 1.07至2.84)也与HF发病密切相关,但由于研究数量不足,无法提供合并风险估计值。
HF发病风险可通过7个常见临床变量进行计算。这些因素相关的风险可指导识别可能从进一步评估和干预中获益的高危人群的策略。